Stefanie Gilles1, Cornelia Blume2,3, Maria Wimmer1,4, Athanasios Damialis1, Laura Meulenbroek4,5, Mehmet Gökkaya1, Carolin Bergougnan1, Selina Eisenbart1, Nicklas Sundell6, Magnus Lindh6, Lars-Magnus Andersson6, Åslög Dahl7, Adam Chaker8, Franziska Kolek1, Sabrina Wagner1, Avidan U Neumann1, Cezmi A Akdis9,10, Johan Garssen4,5, Johan Westin6, Belinda Van't Land5,11, Donna E Davies2,3, Claudia Traidl-Hoffmann1,10. 1. Chair and Institute of Environmental Medicine, UNIKA-T, Technical University of Munich and Helmholtz Zentrum München, Augsburg, Germany. 2. Faculty of Medicine, Academic Unit of Clinical and Experimental Sciences, University of Southampton, Southampton, UK. 3. Southampton NIHR Respiratory Biomedical Research Unit, University Hospital Southampton, Southampton, UK. 4. Division of Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands. 5. Department of Immunology, Nutricia Research, Utrecht, The Netherlands. 6. Department of Infectious Diseases/Clinical Virology, University of Gothenburg, Gothenburg, Sweden. 7. Department of Biological and Environmental Sciences, Faculty of Sciences, University of Gothenburg, Gothenburg, Sweden. 8. ENT Department, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany. 9. Swiss Institute of Allergy and Asthma Research (SIAF), University Zurich, Davos, Switzerland. 10. Christine-Kühne-Center for Allergy Research and Education (CK-Care), Davos, Switzerland. 11. Laboratory of Translational Immunology, The Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.
Abstract
BACKGROUND: Hundreds of plant species release their pollen into the air every year during early spring. During that period, pollen allergic as well as non-allergic patients frequently present to doctors with severe respiratory tract infections. Our objective was therefore to assess whether pollen may interfere with antiviral immunity. METHODS: We combined data from real-life human exposure cohorts, a mouse model and human cell culture to test our hypothesis. RESULTS: Pollen significantly diminished interferon-λ and pro-inflammatory chemokine responses of airway epithelia to rhinovirus and viral mimics and decreased nuclear translocation of interferon regulatory factors. In mice infected with respiratory syncytial virus, co-exposure to pollen caused attenuated antiviral gene expression and increased pulmonary viral titers. In non-allergic human volunteers, nasal symptoms were positively correlated with airborne birch pollen abundance, and nasal birch pollen challenge led to downregulation of type I and -III interferons in nasal mucosa. In a large patient cohort, numbers of rhinoviruspositive cases were correlated with airborne birch pollen concentrations. CONCLUSION: The ability of pollen to suppress innate antiviral immunity, independent of allergy, suggests that high-risk population groups should avoid extensive outdoor activities when pollen and respiratory virus seasons coincide.
BACKGROUND: Hundreds of plant species release their pollen into the air every year during early spring. During that period, pollen allergic as well as non-allergic patients frequently present to doctors with severe respiratory tract infections. Our objective was therefore to assess whether pollen may interfere with antiviral immunity. METHODS: We combined data from real-life human exposure cohorts, a mouse model and human cell culture to test our hypothesis. RESULTS: Pollen significantly diminished interferon-λ and pro-inflammatory chemokine responses of airway epithelia to rhinovirus and viral mimics and decreased nuclear translocation of interferon regulatory factors. In mice infected with respiratory syncytial virus, co-exposure to pollen caused attenuated antiviral gene expression and increased pulmonary viral titers. In non-allergic human volunteers, nasal symptoms were positively correlated with airborne birch pollen abundance, and nasal birch pollen challenge led to downregulation of type I and -III interferons in nasal mucosa. In a large patient cohort, numbers of rhinoviruspositive cases were correlated with airborne birch pollen concentrations. CONCLUSION: The ability of pollen to suppress innate antiviral immunity, independent of allergy, suggests that high-risk population groups should avoid extensive outdoor activities when pollen and respiratory virus seasons coincide.
Authors: William R L Anderegg; John T Abatzoglou; Leander D L Anderegg; Leonard Bielory; Patrick L Kinney; Lewis Ziska Journal: Proc Natl Acad Sci U S A Date: 2021-02-16 Impact factor: 11.205
Authors: Susan C Anenberg; Shannon Haines; Elizabeth Wang; Nicholas Nassikas; Patrick L Kinney Journal: Environ Health Date: 2020-12-07 Impact factor: 5.984
Authors: Athanasios Damialis; Stefanie Gilles; Mikhail Sofiev; Viktoria Sofieva; Franziska Kolek; Daniela Bayr; Maria P Plaza; Vivien Leier-Wirtz; Sigrid Kaschuba; Lewis H Ziska; Leonard Bielory; László Makra; Maria Del Mar Trigo; Claudia Traidl-Hoffmann Journal: Proc Natl Acad Sci U S A Date: 2021-03-23 Impact factor: 11.205
Authors: Fiona Tummon; Lucas Alados Arboledas; Maira Bonini; Benjamin Guinot; Martin Hicke; Christophe Jacob; Vladimir Kendrovski; William McCairns; Eric Petermann; Vincent-Henri Peuch; Oliver Pfaar; Michaël Sicard; Branko Sikoparija; Bernard Clot Journal: Clin Transl Allergy Date: 2021-05-02 Impact factor: 5.657